Agomab Therapeutics NV reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Antwerpen
SEC filing record 1 source field available
Fiscal year end
31 December
Agomab Therapeutics NV has filed 41 SEC EDGAR filings since 20 Jun 2024
  • Filter by type:
  • 20-F
  • 6-K

SEC filing history

Showing 1-9 of 9 matching filings.

Per page
25
Current page
1
6-K File 001-43098

FORM 6-K

Filing date
14 Sep 2026
Reporting date
14 Sep 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
11 Sep 2026
Reporting date
11 Sep 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
10 Aug 2026
Reporting date
10 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

6-K

Filing date
06 Aug 2026
Reporting date
06 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
23 Jun 2026
Reporting date
23 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
27 May 2026
Reporting date
27 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
24 Apr 2026
Reporting date
24 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
05 Mar 2026
Reporting date
05 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-43098

FORM 6-K

Filing date
09 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .